SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyliion Holdings Corp. engages in the development of sustainable electricity-producing technology. It focuses on providing modular power plant technology that can operate on various fuel sources through the KARNO power module. The company was founded by Thomas J. Healy in 2015 and is headquartered in Cedar Park, TX.

Hyliion Holdings Corporation - Ordinary Shares - Class A

Hyliion Holdings Corp

Hyliion Holdings Corp. is surging as investors shift focus toward its KARNO generator technology, which is being positioned as a key solution for AI data center power demands and military defense applications. Community members are actively debating the company's pivot from electric powertrains to stationary power, with many pointing to upcoming earnings, potential institutional re-ratings, and ongoing military trial developments as catalysts for recent momentum.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is capturing investor attention following a series of strategic updates, including a significant revenue outlook increase driven by resilient travel demand that is helping to offset the pressure of surging jet fuel costs. The community is actively debating the stock's stability, balancing bullish sentiment around Delta's premium-focused strategy against broader market concerns regarding geopolitical tensions and the industry-wide impact of energy price volatility.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is experiencing heightened investor focus amid ongoing volatility in the cybersecurity sector, fueled by intense community debates over the impact of new AI models on traditional security platforms. Market participants are actively scrutinizing the stock's valuation and technical support levels, with discussions centered on whether current price levels represent a deep-value opportunity or a risk of further sector rotation.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is experiencing significant investor interest driven by recent Department of Energy funding awards and the broader strategic focus on establishing a secure, domestic rare earth supply chain. Market participants are actively debating the company's long-term growth potential and its ability to compete with global suppliers amidst heightened geopolitical tensions.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is trending as investors weigh its potential as a consolidation target following reports of early-stage merger talks, while the company simultaneously works to capture market share from the recent liquidation of Spirit Airlines. The stock is seeing high volatility and heavy short interest, with the community actively debating whether it remains a distressed asset or a prime acquisition candidate for larger carriers.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is trending as investors aggressively hedge against small-cap volatility, driven by concerns over surging bond yields, persistent inflationary pressures, and the ongoing geopolitical deadlock surrounding the Strait of Hormuz. Community discussion is heavily focused on the disconnect between institutional options hedging and market sentiment, with many debating whether the current pullback is a healthy consolidation or a significant bull trap amid an uncertain energy landscape.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. is trending as the market reacts to the finalized 2027 CMS Medicare Advantage rate announcement, which exceeded analyst expectations and provided a significant boost to managed care stocks. Investors are actively discussing the sector's recovery potential, debating the long-term impact of regulatory policy on medical loss ratios, and closely watching for further developments regarding Medicaid funding and ACA subsidy extensions.

RoboStrategy, Inc. is a non-diversified, closed-end management investment company, which engages in investing in equity and equity-linked securities of private and public companies operating in the fields of robotics and embodied artificial intelligence. The company was founded on May 23, 2025 and is headquartered in San Juan, Puerto Rico.

RoboStrategy Inc

RoboStrategy, Inc.

RoboStrategy, Inc. is trending as retail investors monitor its volatility and high-profile exposure to private physical AI and robotics firms, with many drawing comparisons to other high-momentum closed-end fund IPOs. While some market participants express caution regarding its premium to NAV and potential for dilution, others are actively trading the name as a speculative play on the long-term growth of the robotics sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending amid heightened volatility as investors react to ongoing uncertainty surrounding a potential peace deal in Iran and reports of internal personnel shifts within the administration. The community remains deeply polarized, with active discussions focusing on the company's financial health, its exposure to cryptocurrency fluctuations, and the broader geopolitical implications of current foreign policy decisions.

Ideal Power, Inc. engages in the development of power converter solutions for photovoltaic generation, grid-storage and electrified vehicle charging. Its products include solar inverters, bi-directional battery, electric vehicle chargers, photovoltaic inverters and battery converters. It is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. The company was founded by William C. Alexander on May 17, 2007 and is headquartered in Austin, TX.

Ideal Power Inc

Ideal Power is trending as investors monitor the company's B-TRAN semiconductor technology, which is being evaluated for high-efficiency applications in data centers and electric vehicle contactors. Community discussion remains focused on the potential of upcoming commercial milestones and strategic partnerships as the company works to scale its fabless production model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What to Know About This Fund's Sale of a Pharma Stock Up 56% in a Year

Key PointsQuantedge Capital exited 89,600 shares of Supernus Pharmaceuticals in the first quarter, with an estimated trade size of $4.56 million based on quarterly average prices...

Supernus Pharmaceuticals Q1 Earnings Call Highlights

Supernus Pharmaceuticals (NASDAQ:SUPN) reported first-quarter 2026 results that management said reflected "a strong start to the year," driven by growth across its key brands and collaboration-related revenue. Chief Executive Officer Jack Khattar highlighted a 56% year-over-year increase in combined...

Supernus (SUPN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Supernus (SUPN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates

Supernus (SUPN) delivered earnings and revenue surprises of +110.71% and +10.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Supernus Pharmaceuticals (NASDAQ:SUPN) Issues Quarterly Earnings Results

Supernus Pharmaceuticals (NASDAQ:SUPN - Get Free Report) issued its earnings results on Tuesday. The specialty pharmaceutical company reported ($0.04) earnings per share (EPS) for the quarter...

Supernus Pharmaceuticals, Inc. $SUPN Shares Sold by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA cut its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent Form...

Bausch Health (BHC) Lags Q1 Earnings Estimates

Bausch (BHC) delivered earnings and revenue surprises of -3.11% and +4.72%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Biogen beats Q1 earnings and revenue estimates, fueled by new drug growth, but cuts 2026 EPS outlook to reflect M&A costs.

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Hold at Zacks Research

Zacks Research upgraded Supernus Pharmaceuticals from a "strong sell" rating to a "hold" rating in a report on Monday...

Supernus Pharmaceuticals (SUPN) to Release Quarterly Earnings on Tuesday

Supernus Pharmaceuticals (NASDAQ:SUPN) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-supernus-pharmaceuticals-inc-stock...

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Current Price	$48.21
Prev Close	$49.38
Open	$49.38
Dividend Yield	0.00%
50-Day Moving Average	$49.91
Beta	0.58
Avg. Volume	538,082.45
PE Ratio	-94.18

52-Week High	$59.68
52-Week Low	$30.83
Market Capitalization	$2.8B
EPS (Annual)	-$0.6829
Price to Book	2.60
Revenue Per Employee	$924,102.83

SUPN
Supernus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest SUPN News

SUPNSupernus Pharmaceuticals Inc